Multimedia
Video
Obeticholic acid reversed NASH liver fibrosis in phase 3 trial
VIENNA – Phase 3 trial results showed obeticholic acid, already FDA approved, is the first drug to reverse liver fibrosis in NASH patients.
Video
Geroscience brings bench science to the real-world problems of aging
NEW ORLEANS – The 30% caloric restriction that works in mice won’t cut it over a person’s lifespan.
Video
Intermittent, but prolonged, calorie restriction may improve metabolic markers
NEW ORLEANS – A clinical trial showed improved metabolic markers in patients who went on the diet, especially in those with higher risk.
Latest News
Oxytocin dampens the brain’s food-related reward circuitry
NEW ORLEANS – The decreased brain activation may underlie oxytocin’s promise as a weight-loss medication.
Conference Coverage
Noninfected children of HIV-positive mothers have high rates of obesity
NEW ORLEANS – Obesity and reactive airway disease are more prevalent in noninfected children of HIV-positive mothers.
Conference Coverage
Hormones taken by transgender female teens affect fat levels, muscle mass
NEW ORLEANS – Insulin resistance was similar to that of a control female population in this pilot study.
Video
BP control slowed brain damage in elderly hypertensives
NEW ORLEANS – Elderly hypertensive patients treated to a systolic blood pressure of 130 mm Hg had less white matter disease progression than...
Daily News Podcast
Genetic signature helps ID MS risk
Amlodipine may be preferable for lowering blood pressure in black patients.
Daily News Podcast
First primary prevention CVD guidelines form ACC, AHA
A smartwatch-based algorithm showed 84% positive predictive value for atrial fibrillation.
Daily News Podcast
Match Day 2019
Overall match numbers are up, but some numbers cause concern.